Know Labs (KNWN) Stock Price, News & Analysis

Company Overview

Know Labs, Inc. focuses on the development and commercialization of proprietary technologies in the United States. Its technology uses spectroscopy to direct electromagnetic energy through a substance or material to capture a molecular signature. The company refers to its technology as Bio-RFID. The Bio-RFID technology can be integrated into various wearable, mobile, or bench-top form factors. Its first application of Bio-RFID technology is a product marketed as a glucose monitor that provide the user with real time information on their blood glucose levels. The company was formerly known as Visualant, Incorporated and changed its name to Know Labs, Inc. in May 2018. Know Labs, Inc. was founded in 1998 and is headquartered in Seattle, Washington.

Key Stats

• Today's Range: N/A
• 50-Day Range: $1.45 to $8.05
• 52-Week Range: N/A
• Volume: 2,146 shs
• Average Volume: 1.03 million shs
• Market Capitalization: $9.00 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

KNWN Stock Analysis - Frequently Asked Questions

How were Know Labs' earnings last quarter?

Know Labs, Inc. (OTCMKTS:KNWN) posted its quarterly earnings results on Friday, February, 14th. The company reported ($1.60) earnings per share (EPS) for the quarter.

When did Know Labs' stock split?

Shares of Know Labs reverse split on Tuesday, February 18th 2025. The 1-40 reverse split was announced on Tuesday, February 18th 2025. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, February 19th 2025. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

How do I buy shares of Know Labs?

Shares of KNWN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Know Labs own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Know Labs investors own include Denali Therapeutics (DNLI), Co-Diagnostics (CODX), Home Depot (HD), Onconova Therapeutics (ONTX), Tonix Pharmaceuticals (TNXP), VBI Vaccines (VBIV) and iBio (IBIO).

Company Calendar

• Last Earnings: 2/14/2025
• Today: 5/24/2025
• Fiscal Year End: 9/30/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Business Services
• Industry: Measuring & controlling devices, not elsewhere classified
• Sub-Industry: Measuring And Control Equipment
• Current Symbol: OTCMKTS:KNWN
• CIK: 1074828
• Web: www.knowlabs.co
• Phone: (206) 903-1351
• Fax: 206-826-0451
• Employees: 20
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($0.20)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-16,580,000.00
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: -470.76%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.60
• Quick Ratio: 0.60

Sales & Book Value

• Annual Sales: $4.36 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.02) per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 111,166,000
• Free Float: 94,046,000
• Market Cap: $9.00 million
• Optionable: Not Optionable
• Beta: 1.50